U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 492

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:55505511-55505737
PCSK9Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(Jul 6, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr1:55524211
GRCh38:
Chr1:55058538
PCSK9S340W, S401W, S407W, S446W, S465W, S466W, S506WHypercholesterolemia, autosomal dominant, 3Likely pathogenic
(Aug 15, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr1:55505624
GRCh38:
Chr1:55039951
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 26, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr1:55521676
GRCh38:
Chr1:55056003
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 8, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr1:55518479
GRCh38:
Chr1:55052806
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 13, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr1:55505731-55505732
GRCh38:
Chr1:55040058-55040059
PCSK9Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(Jun 29, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr1:55523206
GRCh38:
Chr1:55057533
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 3, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr1:55512328
GRCh38:
Chr1:55046655
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 19, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr1:55505726
GRCh38:
Chr1:55040053
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 22, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr1:55512232
GRCh38:
Chr1:55046559
PCSK9D21N, D187N, D82N, D146NHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Jan 26, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr1:55524339-55524340
GRCh38:
Chr1:55058666-55058667
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 26, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr1:55521861
GRCh38:
Chr1:55056188
PCSK9E333G, E268G, E313G, E207G, E332G, E373GHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Oct 20, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr1:55509593
GRCh38:
Chr1:55043920
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Mar 26, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr1:55525215
GRCh38:
Chr1:55059542
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Apr 23, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr1:55505596
GRCh38:
Chr1:55039923
PCSK9R29HHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Dec 25, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr1:55512237
GRCh38:
Chr1:55046564
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jan 2, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr1:55525355
GRCh38:
Chr1:55059682
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Oct 19, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr1:55505698
GRCh38:
Chr1:55040025
PCSK9F64fsHypercholesterolemia, autosomal dominant, 3Uncertain significance
(May 7, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr1:55509717
GRCh38:
Chr1:55044044
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 24, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr1:55521781
GRCh38:
Chr1:55056108
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 23, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr1:55518045
GRCh38:
Chr1:55052372
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Feb 25, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr1:55505573-55505574
GRCh38:
Chr1:55039900-55039901
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 22, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr1:55505645
GRCh38:
Chr1:55039972
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 10, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr1:55509689
GRCh38:
Chr1:55044016
PCSK9S168R, S127R, S2RHypercholesterolemia, autosomal dominant, 3Pathogenic
(Aug 30, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr1:55527043
GRCh38:
Chr1:55061370
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 18, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr1:55529237
GRCh38:
Chr1:55063564
PCSK9A562P, A668P, A728P, A688P, A520P, A629P, A687P, A623P, A701PHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr1:55523839
GRCh38:
Chr1:55058166
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 31, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr1:55525174
GRCh38:
Chr1:55059501
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jul 29, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr1:55524166
GRCh38:
Chr1:55058493
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 13, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr1:55529071
GRCh38:
Chr1:55063398
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 30, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:55517973
GRCh38:
Chr1:55052300
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Mar 19, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr1:55523096
GRCh38:
Chr1:55057423
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 8, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr1:55517980
GRCh38:
Chr1:55052307
PCSK9L226V, L121V, L166V, L185V, L60VHypercholesterolemia, autosomal dominant, 3Uncertain significance
(May 20, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr1:55509545
GRCh38:
Chr1:55043872
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 7, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr1:55524214
GRCh38:
Chr1:55058541
PCSK9G466E, G408E, G402E, G467E, G341E, G447E, G507ECardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(Jul 30, 2019)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr1:55518015
GRCh38:
Chr1:55052342
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:55505567
GRCh38:
Chr1:55039894
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Feb 7, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr1:55512312
GRCh38:
Chr1:55046639
PCSK9Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotypeLikely benign
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr1:55523756
GRCh38:
Chr1:55058083
PCSK9E410K, E346K, E391K, E285K, E411K, E451Knot specified, Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:55529053
GRCh38:
Chr1:55063380
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jan 16, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr1:55509695
GRCh38:
Chr1:55044022
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Dec 25, 2020)
criteria provided, single submitter
42.
GRCh37:
Chr1:55518364
GRCh38:
Chr1:55052691
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 12, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr1:55525230
GRCh38:
Chr1:55059557
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 16, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr1:55524339-55524340
GRCh38:
Chr1:55058666-55058667
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Oct 26, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr1:55518457
GRCh38:
Chr1:55052784
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Apr 14, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr1:55505531
GRCh38:
Chr1:55039858
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Nov 18, 2020)
criteria provided, single submitter
47.
GRCh37:
Chr1:55524236
GRCh38:
Chr1:55058563
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Oct 25, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr1:55523740
GRCh38:
Chr1:55058067
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Feb 11, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr1:55518018
GRCh38:
Chr1:55052345
PCSK9Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotypeLikely benign
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr1:55524339-55524340
GRCh38:
Chr1:55058666-55058667
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 20, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr1:55524333
GRCh38:
Chr1:55058660
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 12, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr1:55524340-55524349
GRCh38:
Chr1:55058667-55058676
PCSK9Hypercholesterolemia, autosomal dominant, 3Benign
(Oct 15, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr1:55518317
GRCh38:
Chr1:55052644
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Feb 17, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr1:55524340-55524345
GRCh38:
Chr1:55058667-55058672
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Oct 5, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr1:55525311
GRCh38:
Chr1:55059638
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 21, 2021)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr1:55505666
GRCh38:
Chr1:55039993
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Dec 10, 2020)
criteria provided, single submitter
57.
GRCh37:
Chr1:55527178
GRCh38:
Chr1:55061505
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Nov 1, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr1:55524340-55524347
GRCh38:
Chr1:55058667-55058674
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Oct 30, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr1:55505537
GRCh38:
Chr1:55039864
PCSK9Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotypeLikely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr1:55512332
GRCh38:
Chr1:55046659
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 27, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr1:55524269
GRCh38:
Chr1:55058596
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Nov 18, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr1:55523138
GRCh38:
Chr1:55057465
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 3, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr1:55518474
GRCh38:
Chr1:55052801
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Apr 21, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr1:55505696
GRCh38:
Chr1:55040023
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr1:55527249
GRCh38:
Chr1:55061576
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 15, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr1:55523165
GRCh38:
Chr1:55057492
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Sep 19, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr1:55524156
GRCh38:
Chr1:55058483
PCSK9Hypercholesterolemia, autosomal dominant, 3Benign
(Nov 1, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr1:55509503
GRCh38:
Chr1:55043830
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Mar 26, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr1:55518079
GRCh38:
Chr1:55052406
PCSK9R218G, R199G, R259G, R93G, R154GHypercholesterolemia, autosomal dominant, 3Likely pathogenic
(Jul 26, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr1:55523011
GRCh38:
Chr1:55057338
PCSK9T335I, T316I, T376I, T210I, T336I, T271IHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr1:55529244
GRCh38:
Chr1:55063571
PCSK9Q689L, Q522L, Q564L, Q670L, Q730L, Q625L, Q631L, Q690L, Q703LHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Oct 12, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr1:55505518
GRCh38:
Chr1:55039845
PCSK9T3NHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr1:55509659
GRCh38:
Chr1:55043986
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 29, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr1:55518382
GRCh38:
Chr1:55052709
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jul 14, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr1:55518016
GRCh38:
Chr1:55052343
PCSK9E197K, E133K, E72K, E238K, E178KHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr1:55523122
GRCh38:
Chr1:55057449
PCSK9S372F, S308F, S353F, S413F, S247F, S373FHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr1:55525327
GRCh38:
Chr1:55059654
PCSK9V558I, V433I, V494I, V572I, V500I, V559I, V599I, V539IHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr1:55505713
GRCh38:
Chr1:55040040
PCSK9A68VHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Sep 6, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr1:55518469
GRCh38:
Chr1:55052796
PCSK9Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(Sep 17, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr1:55529060
GRCh38:
Chr1:55063387
PCSK9E628K, E461K, E564K, E570K, E629K, E642K, E669K, E503K, E609KFamilial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3Uncertain significance
(Aug 13, 2021)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr1:55509624
GRCh38:
Chr1:55043951
PCSK9G106RHypercholesterolemia, autosomal dominant, 3Conflicting interpretations of pathogenicity
(Aug 7, 2021)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr1:55523061
GRCh38:
Chr1:55057388
PCSK9G352W, G227W, G353W, G288W, G333W, G393WHypercholesterolemia, autosomal dominant, 3Uncertain significance
(Nov 3, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr1:55523137
GRCh38:
Chr1:55057464
PCSK9T377N, T313N, T358N, T418N, T378N, T252NHypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemiaUncertain significance
(Oct 20, 2021)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr1:55518321
GRCh38:
Chr1:55052648
PCSK9Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemiaUncertain significance
(Feb 3, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr1:55512197
GRCh38:
Chr1:55046524
PCSK9A134DHypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemiaUncertain significance
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr1:55523851
GRCh38:
Chr1:55058178
PCSK9Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3
Conflicting interpretations of pathogenicity
(Oct 16, 2021)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr1:55527175
GRCh38:
Chr1:55061502
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr1:55527049
GRCh38:
Chr1:55061376
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jul 31, 2019)
criteria provided, single submitter
89.
GRCh37:
Chr1:55517988
GRCh38:
Chr1:55052315
PCSK9Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotypeLikely benign
(Jun 17, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr1:55527130
GRCh38:
Chr1:55061457
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Dec 5, 2020)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr1:55524239
GRCh38:
Chr1:55058566
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:55505657
GRCh38:
Chr1:55039984
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Mar 22, 2019)
criteria provided, single submitter
93.
GRCh37:
Chr1:55512249
GRCh38:
Chr1:55046576
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Apr 9, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr1:55523030
GRCh38:
Chr1:55057357
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 13, 2019)
criteria provided, single submitter
95.
GRCh37:
Chr1:55529084
GRCh38:
Chr1:55063411
PCSK9S636R, S578R, S617R, S511R, S572R, S650R, S677R, S469R, S637RHypercholesterolemia, autosomal dominant, 3Likely pathogenic
(May 24, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr1:55505666
GRCh38:
Chr1:55039993
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 15, 2019)
criteria provided, single submitter
97.
GRCh37:
Chr1:55527052
GRCh38:
Chr1:55061379
PCSK9Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3Likely benign
(Aug 7, 2021)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr1:55505606
GRCh38:
Chr1:55039933
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(May 13, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr1:55523018
GRCh38:
Chr1:55057345
PCSK9Hypercholesterolemia, autosomal dominant, 3Likely benign
(Feb 8, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr1:55518427
GRCh38:
Chr1:55052754
PCSK9Cardiovascular phenotype, not provided, Hypercholesterolemia, autosomal dominant, 3
Likely benign
(Jan 1, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination